The price of Sotera Health Co (NASDAQ:SHC) shares last traded on Wall Street fell -2.04% to $11.54.
SHC stock price is now -23.80% away from the 50-day moving average and -25.57% away from the 200-day moving average. The market capitalization of the company currently stands at $3.26B.
On June 26, 2023, KeyBanc Capital Markets Upgraded its previous ‘Sector Weight’ rating to ‘Overweight’ on the stock keeping its target price maintained at $24, while ‘JP Morgan’ rates the stock as ‘Neutral’
In other news, WARBURG PINCUS & CO., Director sold 16,594,363 shares of the company’s stock on Mar 04 ’24. The stock was sold for $237,423,849 at an average price of $14.31. Upon completion of the transaction, the Director now directly owns 88,822,952 shares in the company, valued at $1.03 billion. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 04 ’24, Director WARBURG PINCUS & CO. sold 16,594,363 shares of the business’s stock. A total of $237,423,849 was realized by selling the stock at an average price of $14.31. This leaves the insider owning 88,822,952 shares of the company worth $1.03 billion. A total of 55.28% of the company’s stock is owned by insiders.
During the past 12 months, Sotera Health Co has had a low of $10.74 and a high of $19.40. As of last week, the company has a debt-to-equity ratio of 5.24, a current ratio of 2.42, and a quick ratio of 2.19. According to the stock market information, the enterprise value for the company is $5.36B, which is based on a 64.22 price-to-earnings ratio, a 5.35 price-to-earnings-growth ratio, and a beta of 2.13. The fifty day moving average price for SHC is $15.05 and a two-hundred day moving average price translates $15.49 for the stock.
The latest earnings results from Sotera Health Co (NASDAQ: SHC) was released for Dec, 2023. According to the Diagnostics & Research Company, earnings per share came in at $0.26, inline with analysts’ expectations of $0.26. This compares to -$1.14 EPS in the same period last year. The net profit margin was 4.86% and return on equity was 12.85% for SHC. The company reported revenue of $310.24 million for the quarter, compared to $251.59 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 23.31 percent. For the current quarter, analysts expect SHC to generate $244.93M in revenue.
